These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10577091)

  • 1. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Morgan RW
    N Engl J Med; 1999 Oct; 341(18):1397; author reply 1398-9. PubMed ID: 10577091
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adverse effects of non-steroidal antirheumatic drugs with special reference to the gastrointestinal tract].
    Hackenthal E
    Z Rheumatol; 1987; 46 Suppl 1():83-8. PubMed ID: 3439373
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Fries JF
    N Engl J Med; 1999 Oct; 341(18):1397-8; author reply 1398-9. PubMed ID: 10577092
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals.
    Greenberg JD; Bingham CO; Abramson SB; Reed G; Kishimoto M; Hinkle K; Kremer J
    Arthritis Rheum; 2006 Aug; 55(4):543-50. PubMed ID: 16874798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal antiinflammatory drugs: benefit/risk evaluation in rheumatic diseases.
    Fenner H
    J Rheumatol Suppl; 1992 Jan; 32():98-9. PubMed ID: 1613741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NSAID prescription in patients with rheumatoid arthritis and cardiovascular disease].
    Pavlović R; Curković B; Babić-Naglić D; Kehler T
    Reumatizam; 2006; 53(1):22-4. PubMed ID: 17580545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.
    Singh G; Ramey DR; Morfeld D; Shi H; Hatoum HT; Fries JF
    Arch Intern Med; 1996 Jul; 156(14):1530-6. PubMed ID: 8687261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSAIDs questionable as first-line therapy for rheumatic conditions in the elderly.
    Salach RH; Calabrese LH
    J Am Osteopath Assoc; 1994 Sep; 94(9):714, 766. PubMed ID: 7995734
    [No Abstract]   [Full Text] [Related]  

  • 9. NSAID toxicity: where are we and how do we go forward?
    Hawkey CJ
    J Rheumatol; 2002 Apr; 29(4):650-2. PubMed ID: 11950001
    [No Abstract]   [Full Text] [Related]  

  • 10. Helicobacter pylori and nonsteroidal antiinflammatory drugs: partners in crime?
    Jones NL; Sherman P; Wang B; Inman RD
    Bull Rheum Dis; 1997 Dec; 46(8):6-8. PubMed ID: 9409058
    [No Abstract]   [Full Text] [Related]  

  • 11. Keeping patients with arthritis out of the hospital.
    Spiegel M
    Manag Care Interface; 1998 Jun; 11(6):81-5. PubMed ID: 10181565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the occurrence of gastrointestinal side-effects of tenoxicam and other nonsteroidal antirheumatic agents in patients with rheumatoid arthritis].
    Vlak T; Jajić I; Bilić A
    Reumatizam; 1996; 43(1):1-9. PubMed ID: 8966374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment].
    Martín de Argila C; Moreira V; Gisbert JP
    An Med Interna; 1995 Feb; 12(2):85-96. PubMed ID: 7749017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory efficacy versus gastrointestinal safety: a dilemma resolved? Introduction.
    Bach GL
    Scand J Rheumatol Suppl; 1992; 96():5-6. PubMed ID: 1439625
    [No Abstract]   [Full Text] [Related]  

  • 15. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in COX-2 selective inhibition.
    Simon LS; Smolen JS; Abramson SB; Appel G; Bombardier C; Brater DC; Breedveld FC; Brune K; Burmester GR; Crofford LJ; Dougados M; DuBois RN; Fitzgerald GA; Frishman W; García Rodríguez LA; Hochberg MC; Kalden JR; Laine L; Langman MJ; Prescott SM; van de Putte LB; Whelton A; White WB; Willaims GH
    J Rheumatol; 2002 Jul; 29(7):1501-10. PubMed ID: 12136912
    [No Abstract]   [Full Text] [Related]  

  • 17. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
    Lazzaroni M; Battocchia A; Bianchi Porro G
    Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs.
    Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR
    Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forthcoming non-steroidal anti-inflammatory drugs: are they really devoid of side effects?
    Bjarnason I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S27-36. PubMed ID: 10379467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The appropriate use of NSAIDs in arthritic conditions.
    Moskowitz RW
    Am J Orthop (Belle Mead NJ); 1996 Sep; 25(9 Suppl):4-6. PubMed ID: 8886211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.